Phase II Trial of Surgical Resection and Heated Intraperitoneal Peritoneal Chemotherapy for Adrenocortical Carcinoma

Clinical Setting

Histologically proven metastatic adrenocortical carcinoma (ACC) evaluable by CT imaging with the majority of disease confined to the peritoneal cavity and surgically resectable to a residual size of less than 1 cm in patients who are >18 years of age.

Study Description

Phase 2 trial to determine efficacy of this therapeutic strategy in ACC. Patients will undergo cytoreductive surgery and heated intraperitoneal chemotherapy.